A monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Page Count: 45
Table of Contents
Market Analysis: Focus on Blood Screening Diagnostics
Overview of Blood Screening
Market Outlook
Major Product Activity
Regional Market
Top Company Briefs
Roche
Abbott
Grifols
Executive News Briefing
Briefs
Changes in Hologic Board of Directors
Invitae Executive Appointed to HITAC Committee
Biodesix Announces Appointment to Board of Directors
Financial Highlights: DiaSorin, Invitae Corporation and Trinity Biotech
Highlights
DiaSorin Reports Strong Growth for Core Segments in Q3 2022
Invitae Reports 16.7% YoY Increase in Q3 2022; Revenue of $133.5 million
Trinity Biotech Highlights Demand from Asia Pacific and Latin America for Hemoglobin Offerings
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
Selected Partnerships and Collaborations
Industry Watch
COVID-19 Update
Region Watch
Regions
Chile
Hungary
Broad-based Company Announcements
Announcements
Foundation Medicine Received FDA Approval for its Liquid CDx
QuidelOrtho Receives Approval for Triage True High-Sensitivity Troponin I Test
bioMerieux Captures CE Mark for VIDAS KUBE
Sysmex Received Japanese Approval of its Alzheimer’s Assay Kit
Abbott’s FreeStyle Libre 3 Integrated with Mylife Loop